Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Randomized Experiments01:13

Randomized Experiments

9.3K
The randomization process involves assigning study participants randomly to experimental or control groups based on their probability of being equally assigned. Randomization is meant to eliminate selection bias and balance known and unknown confounding factors so that the control group is similar to the treatment group as much as possible. A computer program and a random number generator can be used to assign participants to groups in a way that minimizes bias.
Simple randomization
Simple...
9.3K
Blinding01:11

Blinding

4.0K
Blinding is a commonly used method of not telling participants which treatment a subject is receiving. Blinding is a critical part of a randomized control trial or RCT. It reduces the bias that affects the results. In an RCT, blinding is used in the form of a placebo. A placebo effect occurs when untreated subjects falsely believe they have received the treatment and report improved symptoms. A placebo or a dummy treatment is administered to subjects to negate the bias caused by such an effect.
4.0K
Bioequivalence Experimental Study Designs: Completely Randomized and Randomized Block Designs01:20

Bioequivalence Experimental Study Designs: Completely Randomized and Randomized Block Designs

354
Bioequivalence experimental study designs are crucial methodologies used in evaluating and comparing the bioavailability of different drug products. These designs are categorized into various types: completely randomized, randomized block, repeated measures, cross and carry-over, and Latin square designs.Completely randomized designs involve randomly allocating treatments to all subjects participating in the experiment. This allocation is achieved by assigning unique random numbers to subjects...
354
Bioequivalence Experimental Study Designs: Repeated Measures, Cross-Over, Carry-Over, and Latin Square Designs01:15

Bioequivalence Experimental Study Designs: Repeated Measures, Cross-Over, Carry-Over, and Latin Square Designs

367
Bioequivalence experimental study designs play a pivotal role in testing the effectiveness of various treatments. Key among these are the repeated measures, cross-over, carry-over, and Latin square designs. In the repeated measures design, each subject receives all treatments, allowing for temporal comparisons. This type of design is useful in reducing variability but requires careful planning to avoid bias.The cross-over design, an economical method, involves sequential administration of...
367
Controls in Experiments01:13

Controls in Experiments

18.7K
When conducting an experiment, it is crucial to have control to reduce bias and accurately measure the dependent variables. It also marks the results more reliable. Controls are elements in an experiment that have the same characteristics as the treatment groups but are not affected by the independent variable. By sorting these data into control and experimental conditions, the relationship between the dependent and independent variables can be drawn. A randomized experiment always includes a...
18.7K
Group Design02:01

Group Design

11.0K
The most basic experimental design involves two groups: the experimental group and the control group. The two groups are designed to be the same except for one difference— experimental manipulation. The experimental group gets the experimental manipulation—that is, the treatment or variable being tested—and the control group does not. Since experimental manipulation is the only difference between the experimental and control groups, we can be sure that any differences between...
11.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Efficacy and tolerability of low versus standard daily doses of antiseizure medications in newly diagnosed focal epilepsy. A multicenter, randomized, single-blind, non-inferiority trial (STANDLOW).

Epilepsia open·2025
Same author

Multicentre case-control study on the association between COVID-19 vaccines and neurological disorders (COVIVAX).

Scientific reports·2025
Same author

Retraction notice to "Neurological outcome of post-anoxic refractory status epilepticus after aggressive treatment" [Epilepsy Behav. 101 (2019) 106374].

Epilepsy & behavior : E&B·2024
Same author

Risk factors for attempted suicide in non-psychotic patients with suicidal ideation.

Rivista di psichiatria·2024
Same author

Prevalence of epilepsy in childhood: An epidemiological study in Sardinia.

Epilepsy & behavior : E&B·2023
Same author

Pitfalls and biases in neuroepidemiological studies of COVID-19 and the nervous system: a critical appraisal of the current evidence and future directions.

Journal of neurology·2023

Related Experiment Video

Updated: Mar 17, 2026

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
04:53

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition

Published on: September 20, 2019

11.4K

The Basic Structure of a Randomized Clinical Trial.

Ettore Beghi1

  • 1Laboratory of Neurological Disorders, IRCCS-Mario Negri Institute for Pharmacological Research, Milan, Italy.

Frontiers of Neurology and Neuroscience
|July 28, 2016
PubMed
Summary
This summary is machine-generated.

Randomized clinical trials (RCTs) are crucial for evaluating drug safety and efficacy. Careful planning, including defining populations and treatment measures, is essential, especially for neurological disorders.

More Related Videos

Author Spotlight: Methodologies and Advancements of Chronic Pain Management Research
08:33

Author Spotlight: Methodologies and Advancements of Chronic Pain Management Research

Published on: January 5, 2024

1.9K
A Within-Subject Experimental Design using an Object Location Task in Rats
09:28

A Within-Subject Experimental Design using an Object Location Task in Rats

Published on: May 6, 2021

5.3K

Related Experiment Videos

Last Updated: Mar 17, 2026

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
04:53

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition

Published on: September 20, 2019

11.4K
Author Spotlight: Methodologies and Advancements of Chronic Pain Management Research
08:33

Author Spotlight: Methodologies and Advancements of Chronic Pain Management Research

Published on: January 5, 2024

1.9K
A Within-Subject Experimental Design using an Object Location Task in Rats
09:28

A Within-Subject Experimental Design using an Object Location Task in Rats

Published on: May 6, 2021

5.3K

Area of Science:

  • Clinical Research
  • Pharmacology
  • Neurology

Background:

  • Clinical trials investigate investigational medicinal products for effects, adverse reactions, and pharmacokinetics.
  • European Union Directive 2001/20/EC defines clinical trial objectives.
  • Assessing safety and efficacy are primary goals of medicinal product investigations.

Purpose of the Study:

  • To outline the essential components for planning and conducting a randomized clinical trial (RCT).
  • To highlight considerations specific to neurological disorders in clinical trial design.
  • To emphasize the role of RCTs in evaluating drug efficacy, tolerability, and safety.

Main Methods:

  • Defining the study population.
  • Implementing random assignment of treatments.
  • Selecting appropriate measures for treatment effects and study duration.
  • Assessing drug tolerability and safety.
  • Considering alternative study design models.

Main Results:

  • RCTs are optimal for discerning treatment effects from prognostic variables.
  • Careful planning ensures the reliability of study outcomes.
  • Specific attention to neurological disorder characteristics is necessary for relevant trial design.

Conclusions:

  • RCTs provide the best evidence for drug efficacy, tolerability, and safety.
  • Study design restrictions, while necessary, can limit generalizability to clinical practice.
  • Adaptation of RCT models is key for addressing the complexities of neurological conditions.